Effect of flestolol on ventricular rate during atrial fibrillation in wolff-parkinson-white syndrome

This publication has 19 references indexed in Scilit:

• Electropharmacology of flestolol for supraventricular tachycardia without associated structural heart disease
  The American Journal of Cardiology, 1987
• Beta-blocker therapy for the Wolff-Parkinson-White syndrome
  The American Journal of Cardiology, 1987
• Effect of Propranolol on Ventricular Rate During Atrial Fibrillation in the Wolff‐Parkinson‐White Syndrome
  Pacing and Clinical Electrophysiology, 1987
• Clinical electrophysiology of flestolol, a potent ultra short-acting beta blocker
  American Heart Journal, 1986
• Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome.
  Circulation, 1984
• Effects of exercise and isoproterenol during atrial fibrillation in patients with wolff-parkinson-white syndrome
  The American Journal of Cardiology, 1983
• Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndrome
  The American Journal of Cardiology, 1982
• Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
  Circulation, 1982
• Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation.
  Circulation, 1977
• Wolff-Parkinson-White syndrome and atrial fibrillation: Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation
  The American Journal of Cardiology, 1974